Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules.

Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules. — المؤلف: Gao, Hong — PloS one 20190506

المؤلف
Gao, Hong
النشر
PloS one 20190506
الوصف
e0207683 p.
الموضوعات
Animals؛ Aorta, Abdominal؛ Cardiovascular Agents؛ Diabetes Mellitus, Experimental؛ Diabetes Mellitus, Type 2؛ Diabetic Angiopathies؛ Disease Models, Animal؛ Drugs, Chinese Herbal